How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies.

El Chaer, Firas; Auletta, Jeffery J; Chemaly, Roy F

El Chaer, Firas; Auletta, Jeffery J; Chemaly, Roy F.

Affiliation

El Chaer F; Division of Hematology and Oncology, Department of Medicine, University of Virginia, Charlottesville, VA.
Auletta JJ; National Marrow Donor Program/Be The Match, Minneapolis, MN.
Chemaly RF; Divisions of Hematology, Oncology, Blood and Marrow Transplant & Infectious Diseases, Nationwide Children's Hospital, Columbus, OH; and.

Blood ; 140(7): 673-684, 2022 08 18.

Article in En | MEDLINE | ID: mdl-35776899

Subject(s)

COVID-19; Hematologic Neoplasms; Adult; COVID-19/complications; COVID-19 Vaccines; Cell- and Tissue-Based Therapy; Hematologic Neoplasms/complications; Hematologic Neoplasms/therapy; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematologic Neoplasms / COVID-19 Limits: Adult / Humans Language: En Journal: Blood Year: 2022 Type: Article Affiliation country: Vatican City

Fulltext

XML

PubMed Links

Search on Google